Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAISI acarbose prevention trial in impaired glucose tolerance
NL-OMON27395Unknown
- Sponsor
- Bayer
- Start
- Jun 1996
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Acarbose with Placebo (2 arms). Primary endpoint: 2-hour venous plasma glucose after oral glucose tolerance test at study end. Status: unknown.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON27395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27395.